Insulin (human) reco (10 mg)

44379551

GIVEQCCTSICSLYQLENYCN FVNQHLCGSHLVEALYLVCGERGFFYTPKT*

(Modifications: Disulfide bridge between 6 - 11, 7 -7*, 20 - 19*)

Endogenous peptide agonist

5807.57

Endogenous insulin receptor agonist (K_i = 4.85 nM). Decreases plasma glucose levels, proteolysis, lipolysis and gluconeogenesis and increases glycogen and fatty acid synthesis in vivo.

Soluble to 20 mg/ml in 0.01 M hydrochloric acid

[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[

C₂₅₇H₃₈₃N₆₅O₇₇S₆

11061-68-0